Trans-3'-hydroxycotinine: disposition kinetics, effects and plasma levels during cigarette smoking
about
Nicotine chemistry, metabolism, kinetics and biomarkersMechanistic insights into nicotine withdrawal.Evaluating the relationship between biomarkers of potential harm and biomarkers of tobacco exposure among current, past, and nonsmokers: data from the National Health and Nutrition Examination Survey 2007-2012.Precision Medicine for Tobacco Dependence: Development and Validation of the Nicotine Metabolite RatioA novel validated procedure for the determination of nicotine, eight nicotine metabolites and two minor tobacco alkaloids in human plasma or urine by solid-phase extraction coupled with liquid chromatography-electrospray ionization-tandem mass spectVariation in trans-3'-hydroxycotinine glucuronidation does not alter the nicotine metabolite ratio or nicotine intake.Clinical considerations in study designs that use cotinine as a biomarker.Optimization and validation of a liquid chromatography-tandem mass spectrometry method for the simultaneous quantification of nicotine, cotinine, trans-3'-hydroxycotinine and norcotinine in human oral fluidOral fluid nicotine markers to assess smoking status and recency of useA comparison of nicotine dose estimates in smokers between filter analysis, salivary cotinine, and urinary excretion of nicotine metabolites.Composition of betel specific chemicals in saliva during betel chewing for the identification of biomarkersRapid nicotine clearance is associated with greater reward and heart rate increases from intravenous nicotineCYP2A6 and CYP2B6 genetic variation and its association with nicotine metabolism in South Western Alaska Native peopleReproducibility of the nicotine metabolite ratio in cigarette smokers.Mesolimbic dopamine and habenulo-interpeduncular pathways in nicotine withdrawal.Environmental and genetic determinants of tobacco use: methodology for a multidisciplinary, longitudinal family-based investigation.Neural response to pictorial health warning labels can predict smoking behavioral change.Simultaneous and sensitive measurement of nicotine, cotinine, trans-3'-hydroxycotinine and norcotinine in human plasma by liquid chromatography-tandem mass spectrometry.Exposure to tobacco smoke and childhood rhinitis: a population-based studyEvaluation of biomarkers of exposure in adult cigarette smokers using Marlboro snus.Occupational exposure of non-smoking restaurant personnel to environmental tobacco smoke in Finland.Detection of tobacco-related biomarkers in urine samples by surface-enhanced Raman spectroscopy coupled with thin-layer chromatography.Effect of nicotine and nicotine metabolites on angiotensin-converting enzyme in human endothelial cells.Evaluation of urinary trans-3'-hydroxycotinine as a biomarker of children's environmental tobacco smoke exposure.Variation in CYP2A6 Activity and Personalized Medicine.Longitudinal Influence of Pregnancy on Nicotine Metabolic Pathways.Relationship between cotinine and trans-3′-hydroxycotinine glucuronidation and the nicotine metabolite ratio in Caucasian smokers
P2860
Q24632647-3E7FFF6D-A7AD-446F-8D19-24234477B99BQ27687645-7A57D61B-C9B6-4E51-89F8-0B7E0D728435Q31109084-47324788-BF72-4E89-80F5-7B9717A3D182Q33821233-C1C6357F-8898-4773-A3D4-8283F64D337FQ34286978-DD1B6956-B9AC-4B58-A6D7-5FEC55AFCCB0Q34926339-D9FCB636-2638-46F3-AB6E-17A46300A712Q35207903-BA329C59-CBCA-4943-9EC2-2609A271E067Q35209224-874FCE56-5137-45FD-A085-B76E01AF4FDAQ35228351-3BD31B65-D346-4C77-BAD8-AF99ACC25C7EQ35230191-A41EAF2C-2148-4BA0-BE50-B3F09D492EABQ35679835-7C5A5C71-9A44-49B3-A0E0-093D1BD45DEFQ35892758-12CB1F1F-2E6E-45A3-B17E-7E79D81D2826Q35949266-44A9748A-F106-4537-8C89-1FE3E3828836Q36084196-2970F1E3-A0FF-4FD8-B6E4-D172C2C77DB0Q36870245-3A35DCED-7301-467D-B8D0-AF6A9221DD83Q36983812-9E926F36-A913-4D90-9941-0AB32087DD46Q37388281-1A32A00D-5BFC-4F51-B48E-BA11E35F1844Q37389703-DF7A6C2E-DE91-4413-9864-0C6197D2CE87Q37644342-37C83803-3D22-4AB9-945C-C473B8702356Q43212396-55E26D4F-3EDE-442E-99A4-28D6459156B4Q43828734-D17EF167-D658-49B5-BDBC-F5EF288C24DFQ44253798-8112A84A-E6DA-4B31-B60D-5A41127B960EQ46209150-B40E36B9-FE49-4D9C-884E-E473E71F1BBEQ46637014-D808A224-8CEC-4FC3-A232-508D6782DF1BQ47163198-17120310-95CF-424D-9D1A-477604604E0BQ47572401-1FE34B7F-6AAC-4883-A665-B4E1C8291A18Q57710071-1FAEBC40-3AC1-4D30-9C43-858F30F2EDA9
P2860
Trans-3'-hydroxycotinine: disposition kinetics, effects and plasma levels during cigarette smoking
description
2001 nî lūn-bûn
@nan
2001 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Trans-3'-hydroxycotinine: disp ...... evels during cigarette smoking
@ast
Trans-3'-hydroxycotinine: disp ...... evels during cigarette smoking
@en
Trans-3'-hydroxycotinine: disp ...... evels during cigarette smoking
@nl
type
label
Trans-3'-hydroxycotinine: disp ...... evels during cigarette smoking
@ast
Trans-3'-hydroxycotinine: disp ...... evels during cigarette smoking
@en
Trans-3'-hydroxycotinine: disp ...... evels during cigarette smoking
@nl
prefLabel
Trans-3'-hydroxycotinine: disp ...... evels during cigarette smoking
@ast
Trans-3'-hydroxycotinine: disp ...... evels during cigarette smoking
@en
Trans-3'-hydroxycotinine: disp ...... evels during cigarette smoking
@nl
P2860
P3181
P1476
Trans-3'-hydroxycotinine: disp ...... evels during cigarette smoking
@en
P2093
P2860
P3181
P356
10.1046/J.1365-2125.2001.01309.X
P407
P577
2001-01-01T00:00:00Z